# Examination of Glutamate and mGluR5 in Psychiatric Disorders

> **NCT02727972** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 180 (estimated)

## Conditions studied

- Major Depressive Disorder
- Post-Traumatic Stress Disorder
- Bipolar Disorder

## Interventions

- **BEHAVIORAL:** Cognitive Testing
- **OTHER:** MRI
- **RADIATION:** PET

## Key facts

- **NCT ID:** NCT02727972
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-21
- **Primary completion:** 2022-01-13
- **Final completion:** 2022-01-13
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02727972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02727972, "Examination of Glutamate and mGluR5 in Psychiatric Disorders". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02727972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*